Influence of combined antihypertensive therapy on plasmatic,vascular-thrombocytic hemostasis and lipid peroxidation in patientswith metabolic syndrome and arterial hypertension

Bûlleten' Sibirskoj Mediciny

N. M. Krasnova¹  E. A. Bushkova¹ 

[1] Сибирский государственный медицинский университет, г. Томск;

关键词: metabolic syndrome;    arterial hypertension;    platelet aggregation;    lipid peroxidation;    enalapril;    verapamil sr;   

DOI  :  10.20538/1682-0363-2007-4-58-63

来源: DOAJ

【 摘 要 】

The impact of antihypertensive therapy with the angiotensin-converting enzyme inhibitor enalapril (enap) and with enalapril in combination with the long-acting calcium channel blocker verapamil SR (isoptin SR) on changes of plasmatic, vascular-thrombocytic hemostasis and lipid peroxidation in patients with metabolic syndrome and arterial hypertension was studied. Combined therapy with enalapril and verapamil significantly reduces the fasting glucose and glycated hemoglobin concentrations, the aggregation activity of thrombocytes in the patient's blood, inhibits the lipid peroxidation, increases the level of high-density lipoprotein cholesterol, and decreases the coefficient of atherogenecity. Combined therapy with enalapril and verapamil SR can be recommended for treatment of arterial hypertension in patients with metabolic syndrome.

【 授权许可】

Unknown